01 1Kopran
01 1ATENOLOL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-01-17
Pay. Date : 2018-09-06
DMF Number : 33007
Submission : 2018-07-27
Status : Active
Type : II
20
Kopran Research Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATENOLOL USP, with a corresponding US DMF Number 33007.
Remarkably, this DMF maintains an Active status since its submission on July 27, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 17, 2019, and payment made on September 06, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
